Mentax

/ Perrigo

In the treatment of interdigital tinea pedis, Mentax should be applied twice daily for 7 days OR once daily for 4 weeks (NOTE: in separate clinical trials, the 7-day dosing regimen was less efficacious than the 4-week regimen. While the clinical significance of this difference is unknown, these data should be carefully considered before selecting the dosage regiment for patients at risk for the development of bacterial cellulitis of the lower extremity associated with interdigital cracking/fissuring).
Patients with tinea corporis or tinea cruris should apply Mentax once daily for two weeks.
Sufficient MentaxCream should be applied to cover affected areas and immediately surrounding skin of patients with interdigital tinea pedis, tinea corporis, and tinea cruris. If a patient shows no clinical improvement after the treatment period, the diagnosis and therapy should be reviewed.

Interdigital tinea pedis, tinea corporis, tinea cruris for up to 4 weeks.

MentaxCream, is contraindicated in individuals who have known or suspected sensitivity to Mentax Cream, or any of its components.

Mentax Cream, is for external use only. If irritation or sensitivity develops with the use of Mentax Cream, treatment should be discontinued and appropriate therapy instituted. Diagnosis of the disease should be confirmed either by culture on an appropriate medium, [except M. furfur (formerly P. orbiculare)] or by direct microscopic examination of infected superficial epidermal tissue in a solution of potassium hydroxide.
Patients who are known to be sensitive to allylamine antifungals should use Mentax Cream with caution, since cross-reactivity may occur.
Use Mentax Cream, as directed by the physician, and avoid contact with the eyes, nose, and mouth, and other mucous membranes.

Adverse events related to the skin.
See prescribing information for full details.

Potential drug interactions between Mentax Cream, and other drugs have not been systematically evaluated.

Pregnancy: There are no adequate and well-controlled studies that have been conducted with topically applied butenafine in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.
Nursing Mothers: It is not known if butenafine HCl is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised in prescribing Mentax Cream, to a nursing woman. Nursing mothers should avoid application of Mentax Cream, to the breast.
See prescribing information for full details.

Overdosage of butenafine HCl in humans has not been reported to date.